{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:19:29Z","timestamp":1785745169837,"version":"3.56.0"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.2169\/internalmedicine.7234-21","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:07:04Z","timestamp":1620943624000},"page":"2145-2148","source":"Crossref","is-referenced-by-count":1,"title":["Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia"],"prefix":"10.2169","volume":"60","author":[{"given":"Naoki","family":"Tanomogi","sequence":"first","affiliation":[{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Otani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Sugitani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Itagaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kiriu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Sterne JAC, Murthy S, Diaz JV, et al.; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA 324: 1330-1341, 2020."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tang C, Wang Y, Lu H, Guan Z, Gu J. Caution against corticosteroid-based COVID-19 treatment. Lancet 395: 1759-1760, 2020.","DOI":"10.1016\/S0140-6736(20)30749-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA 324: 1308, 2020.","DOI":"10.1001\/jama.2020.17021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Horby P, Lim WS, Emberson JR, et al.; Recovery Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. NEJM 384: 693-704, 2021.","DOI":"10.1056\/NEJMoa2021436"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dequin PF, Heming N, Meziani F, et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically Ill patients with COVID-19. JAMA 324: 1-9, 2020.","DOI":"10.1001\/jama.2020.16761"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 357: 1415, 2017.","DOI":"10.1136\/bmj.j1415"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 5: 33, 2020.","DOI":"10.1038\/s41392-020-0148-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J 56: 2002049, 2020.","DOI":"10.1183\/13993003.02049-2020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schwartzman RA, Cidlowski JA. Glucocorticoid-induced apoptosis of lymphoid cells. Int Arch Allergy Immunol 105: 347-354, 1994.","DOI":"10.1159\/000236781"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician&apos;s perspective. Diabetes Metab Syndr 14: 971-978, 2020.","DOI":"10.1016\/j.dsx.2020.06.054"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/13\/60_7234-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T04:53:41Z","timestamp":1625288021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/13\/60_7234-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":10,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7234-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"7234-21"}}